Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin 1000 mg solid dose for acute low back pain
2004-005079-40Phase 3Completed
- Sponsor
- Bayer
- Start
- Aug 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of aspirin in lumbodynia (LBP) (3 arms), sponsored by Bayer. Primary endpoint: Pain intensity AUC over 48 hours. Started Aug 2005; status: completed.
02
Drugs
aspirin
03
Conditions
lumbodynia (LBP)
Beyond the preview
Go deeper on 2004-005079-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-005079-40.